Feasibility and comparison of visual acuity testing methods in children with neurofibromatosis type 1 and/or optic pathway gliomas

Investigative Ophthalmology and Visual Science

Volumn 54, Issue 2, 2013, Pages 1034-1038

  Avery, Robert A ^a   Bouffet, Eric ^b   Packer, Roger J ^a   Reginald, Arun ^b  

^a CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

^b HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AGE; ARTICLE; CHILD; FEMALE; HOTV TEST; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; NEUROFIBROMATOSIS; OPTIC NERVE GLIOMA; PRESCHOOL CHILD; PRIORITY JOURNAL; PROSPECTIVE STUDY; SCHOOL CHILD; TELLER GRATING ACUITY; VISION TEST; VISUAL ACUITY;

AMBLYOPIA; CHILD; CHILD, PRESCHOOL; DIAGNOSIS, DIFFERENTIAL; FEASIBILITY STUDIES; FEMALE; HUMANS; MALE; NEUROFIBROMATOSIS 1; OPTIC NERVE GLIOMA; OPTIC NERVE NEOPLASMS; RETROSPECTIVE STUDIES; VISION TESTS; VISUAL ACUITY;

EID: 84874983319     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.12-11385     Document Type: Article

References (31)

1. Beck RW, Maguire MG, Bressler NM, Glassman AR, Lindblad AS, Ferris FL. Visual acuity as an outcome measure in clinical trials of retinal diseases. Ophthalmology. 2007;114:1804-1809.
2. Ferris FL III, Kassoff A, Bresnick GH, Bailey I. New visual acuity charts for clinical research. Am J Ophthalmol. 1982;94:91-96.
3. Beck RW, Moke PS, Turpin AH, et al. A computerized method of visual acuity testing: adaptation of the early treatment of diabetic retinopathy study testing protocol. Am J Ophthalmol. 2003;135:194-205.
4. Good WV, Hardy RJ, Dobson V, et al. Final visual acuity results in the early treatment for retinopathy of prematurity study. Arch Ophthalmol. 2010;128:663-671.
5. Moke PS, Turpin AH, Beck RW, et al. Computerized method for visual acuity testing: adaptation of the amblyopia treatment study visual acuity testing protocol. Am J Ophthalmol. 2001; 132:903-909.
6. Drover JR, Felius J, Cheng CS, Morale SE, Wyatt L, Birch EE. Normative pediatric visual acuity using single surrounded HOTV optotypes on the Electronic Visual Acuity Tester following the Amblyopia Treatment Study protocol. J AAPOS. 2008;12:145-149.
7. Leone JF, Gole GA, Mitchell P, Kifley A, Pai ASI, Rose KA. Visual acuity testability and comparability in Australian preschool children: The Sydney Paediatric Eye Disease Study. Eye. 2012; 26:925-932.
8. Drover JR, Wyatt LM, Stager DR, Birch EE. The Teller acuity cards are effective in detecting amblyopia. Optom Vis Sci. 2009;86:755-759.
9. Lambert SR, Lynn M, Drews-Botsch C, et al. A comparison of grating visual acuity, strabismus, and reoperation outcomes among children with aphakia and pseudophakia after unilateral cataract surgery during the first six months of life. J AAPOS. 2001;5:70-75.
10. Dobson V, Quinn GE, Biglan AW, Tung B, Flynn JT, Palmer EA. Acuity card assessment of visual function in the cryotherapy for retinopathy of prematurity trial. Invest Ophthalmol Vis Sci. 1990;31:1702-1708.
11. Dobson V, Quinn GE, Siatkowski RM, et al. Agreement between grating acuity at age 1 year and Snellen acuity at age 5.5 years in the preterm child. Cryotherapy for Retinopathy of Prematurity Cooperative Group. Invest Ophthalmol Vis Sci. 1999;40:496-503.
12. Dobson V, Quinn GE, Summers CG, Hardy RJ, Tung B, Good WV. Grating visual acuity results in the early treatment for retinopathy of prematurity study. Arch Ophthalmol. 2011;129: 840-846.
13. Weiss AH, Kelly JP. Acuity development in infantile nystagmus. Invest Ophthalmol Vis Sci. 2007;48:4093-4099.
14. Fu VL, Bilonick RA, Felius J, Hertle RW, Birch EE. Visual acuity development of children with infantile nystagmus syndrome. Invest Ophthalmol Vis Sci. 2011;52:1404-1411.
15. Lambert SR, Buckley EG, Drews-Botsch C, et al. The infant aphakia treatment study: design and clinical measures at enrollment. Arch Ophthalmol. 2010;128:21-27.
16. Dobson V, Quinn GE, Tung B, Palmer EA, Reynolds JD. Comparison of recognition and grating acuities in very-lowbirth-weight children with and without retinal residua of retinopathy of prematurity. Cryotherapy for Retinopathy of Prematurity Cooperative Group. Invest Ophthalmol Vis Sci. 1995;36:692-702.
17. Kushner BJ, Lucchese NJ, Morton GV. Grating visual acuity with Teller cards compared with Snellen visual acuity in literate patients. Arch Ophthalmol. 1995;113:485-493.
18. Listernick R, Ferner RE, Piersall L, Sharif S, Gutmann DH, Charrow J. Late-onset optic pathway tumors in children with neurofibromatosis 1. Neurology. 2004;63:1944-1946.
19. Singhal S, Birch JM, Kerr B, Lashford L, Evans DG. Neurofibromatosis type 1 and sporadic optic gliomas. Arch Dis Child. 2002;87:65-70.
20. Nicolin G, Parkin P, Mabbott D, et al. Natural history and outcome of optic pathway gliomas in children. Pediatr Blood Cancer. 2009;53:1231-1237.
21. Listernick R, Ferner RE, Liu GT, Gutmann DH. Optic pathway gliomas in neurofibromatosis-1: controversies and recommendations. Ann Neurol. 2007;61:189-198.
22. North KN, Riccardi V, Samango-Sprouse C, et al. Cognitive function and academic performance in neurofibromatosis. 1: consensus statement from the NF1 Cognitive Disorders Task Force. Neurology. 1997;48:1121-1127.
23. Ferner RE, Huson SM, Thomas N, et al. Guidelines for the diagnosis and management of individuals with neurofibromatosis 1.
24. Avery RA, Ferner RE, Listernick R, Fisher MJ, Gutmann DH, Liu GT. Visual acuity in children with low grade gliomas of the visual pathway: implications for patient care and clinical research. J Neurooncol. 2012;110:1-7.
25. Holmes JM, Beck RW, Repka MX, et al. The amblyopia treatment study visual acuity testing protocol. Arch Ophthalmol. 2001;119:1345-1353.
26. Cotter SA, Tarczy-Hornoch K, Wang Y, et al. Visual acuity testability in African-American and Hispanic children: the multi-ethnic pediatric eye disease study. Am J Ophthalmol. 2007;144:663-667.
27. Friedman DS, Repka MX, Katz J, et al. Prevalence of decreased visual acuity among preschool-aged children in an American urban population. Ophthalmology. 2008;115:1786-1795.
28. Ferner RE. Neurofibromatosis 1 and neurofibromatosis 2: a twenty first century perspective. Lancet Neurol. 2007;6:340-351.
29. Mash C, Dobson V. Long-term reliability and predictive validity of the Teller acuity card procedure. Vision Res. 1998;38:619-626.
30. Birch EE, Spencer R. Visual outcome in infants with cicatricial retinopathy of prematurity. Invest Ophthalmol Vis Sci. 1991; 32:410-415.
31. Mash C, Dobson V, Carpenter N. Interobserver agreement for measurement of grating acuity and interocular acuity differences with the Teller acuity card procedure. Vision Res. 1995; 35:303-312.